Mantle Cell Lymphoma

>

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Latest News

Image of 'FDA Approval'
FDA Approves Calquence Combo for Mantle Cell Lymphoma

January 16th 2025

The Food and Drug Administration has granted traditional approval to Calquence with bendamustine and Rituxan for some patients with MCL.

Illustration of cross hairs on cancer in the blood.
Tecartus After Outpatient Lymphodepletion Safe, Effective in B-ALL and MCL

December 16th 2024

Illustration of mantle cell lymphoma cells.
Survival Outcomes Not Improved With Autologous Stem Cell Transplant in MCL

December 11th 2024

Image of a heart monitor.
Heart Risk May Occur Less With Some BTK Inhibitors in B-Cell Blood Cancers

December 9th 2024

Danielia Cotton with her husband and daughter.
Parenting and Cancer: How Much Do Kids Need to Know?

November 26th 2024

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Dr. Luhua (Michael) Wang
<1
...
34567